Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index

BACKGROUND: Optimal ustekinumab levels (UST) in Crohn disease (CD) treatment have not been defined. We set out to define the optimal UST to differentiate between remission and active CD, as defined using the serum-based endoscopic healing index (EHI). METHODS: Paired serum UST and EHI tests were ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Walshe, Margaret, Borowski, Krzysztof, Battat, Robert, Hudesman, David, Wolf, Douglas C, Okada, Lauren, Jain, Anjali, Silverberg, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802063/
https://www.ncbi.nlm.nih.gov/pubmed/36776648
http://dx.doi.org/10.1093/crocol/otab032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802063/
https://www.ncbi.nlm.nih.gov/pubmed/36776648
http://dx.doi.org/10.1093/crocol/otab032

Ejemplares similares